VCYT.NASDAQVeracyte, INC

SCHEDULE 13G/A: ARK Investment Management Reduces Stake in Veracyte, Inc. Below 5%

Sentiment:

Beneficial Ownership Amendment


ARK Investment Management LLC has filed an Amendment No. 10 to its Schedule 13G, disclosing a reduction in its beneficial ownership of Veracyte, Inc. common stock to 4.48%.

Worse than expectedThe filing indicates that ARK Investment Management LLC has reduced its stake in Veracyte, Inc. to below 5% (specifically 4.48%). This suggests a decrease in their position, which can be interpreted negatively by the market as a significant institutional investor is divesting shares.

Summary

  • ARK Investment Management LLC has filed an Amendment No. 10 to its Schedule 13G regarding its beneficial ownership in Veracyte, Inc.
  • The filing indicates that ARK Investment Management LLC now beneficially owns 3,491,379 shares of Veracyte, Inc. common stock.
  • This represents 4.48% of the total class of securities, a reduction from previous filings which would have been above the 5% threshold to trigger the initial 13G.
  • ARK Investment Management LLC holds sole voting power over 3,386,211 shares and shared voting power over 64,844 shares.
  • The firm has sole dispositive power over 3,491,379 shares and no shared dispositive power.
  • The event date requiring this filing was April 30, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative as a significant institutional investor (ARK Investment Management LLC) has reduced its stake in Veracyte, Inc. to below the 5% reporting threshold, implying a divestment of shares.

Future Outlook

NA

Industry Context

This filing reflects a change in a significant institutional investor's position in a biotechnology or diagnostics company. Such changes can be observed across various sectors as investment firms rebalance portfolios based on market conditions, company performance, or strategic shifts.

Stakeholder Impact

  • Shareholders: The reduction in stake by a prominent investment firm like ARK Investment Management LLC could lead to negative market sentiment and potentially impact the share price of Veracyte, Inc.

Key Dates

DateDescription
04/30/2025Date of event which requires the filing of this statement (reduction in beneficial ownership).
05/07/2025Date the Schedule 13G Amendment No. 10 was signed and filed.

Keywords

Veracyte Inc., ARK Investment Management LLC, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Investment Adviser, Ownership Disclosure

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.